Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,397 across all filing types
Latest filing 2019-10-01 Regulatory Filings
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
TOTAL VOTING RIGHTS
Regulatory Filings
2019-10-01 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document explicitly starts with an 'RNS Number' and is dated '01 October 2019'. The content discusses 'Voting Rights and Capital' and references compliance with the 'UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1', detailing the total number of voting rights. This type of mandatory, periodic disclosure regarding capital structure and voting rights, distributed via the London Stock Exchange's RNS service, fits best under the general 'Regulatory Filings' category (RNS) as it is not specifically covered by other codes like DIRS (Director's Dealing) or SHA (Share Issue/Capital Change), although it relates to capital. Given the explicit RNS header and the nature of the announcement, RNS is the most appropriate classification.
2019-10-01 English
ASTRAZENECA DIVESTS RIGHTS FOR LOSEC TO CHEPLAPHAR
Regulatory Filings
2019-10-01 English
UPDATE ON US REGULATORY REVIEW OF PT010 IN COPD
Regulatory Filings
2019-10-01 English
AstraZeneca divests rights for Losec to Cheplaphar
M&A Activity Classification · 99% confidence The document begins with an 'RNS Number' and the date, indicating it is a regulatory news service announcement from the London Stock Exchange. The content describes a specific corporate action: AstraZeneca divesting commercial rights for the drug Losec to Cheplapharm for a specified financial consideration ($243 million upfront plus milestones). This is a material event announcement that does not fit the specific definitions for earnings releases (ER), capital changes (CAP/SHA), director dealings (DIRS), or formal reports (10-K/IR). Since it is a general regulatory announcement concerning a transaction/divestiture that doesn't fit other specific codes (like M&A/TAR), the most appropriate general regulatory filing category is RNS (Regulatory Filings), which serves as a fallback for miscellaneous regulatory announcements.
2019-10-01 English
Update on US regulatory review of PT010 in COPD
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated '01 October 2019'. It announces an 'Update on US regulatory review of PT010 in COPD' following a complete response letter from the FDA. This is a specific corporate announcement regarding regulatory interaction and clinical trial data updates, not a comprehensive financial report (like 10-K or IR) or a general earnings release (ER). Since it is a formal announcement disseminated via RNS (Regulatory News Service) concerning a specific corporate event (drug regulatory status), and it doesn't fit perfectly into the other specific categories like M&A (TAR) or Director's Dealing (DIRS), the most appropriate classification is the general regulatory announcement category, RNS. The document length is substantial (8526 chars), suggesting it is the full announcement, not just a brief notice of publication (RPA).
2019-10-01 English

Browse filings by year

34 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.